cytomegalovirus

Photo of someone standing on a rock looking off to the left using binoculars
Biotech

Investors home in on Moderna's RSV, CMV prospects

Moderna's R&D chief believes both interim and full efficacy analyses of the company's CMV vaccine could be ready in 2024.
Max Bayer Feb 22, 2024 10:09am
Stop sign

Hookipa halts spending on CMV vaccine after seeing phase 2 data

Mar 15, 2023 9:14am
Cytomegalovirus CMV herpes herpesvirus virus

New antiviral class could halt treatment-resistant viruses

May 16, 2022 3:10pm